arrow_back Back to App

Increased Alzheimer's Research Funding: New Budgeting Requirements

This act mandates the National Institutes of Health to submit an annual detailed budget plan for Alzheimer's initiatives. This aims to ensure better funding and planning for research, potentially accelerating the search for effective treatments and support for patients and their families.
Key points
Annual Budget Plans: The National Institutes of Health must submit a detailed annual budget for Alzheimer's research to the President and Congress.
Increased Funding Transparency: Citizens can expect greater transparency in how funds for Alzheimer's are spent, potentially leading to more efficient use of taxpayer money.
Potential for Increased Investment: The act aims to boost investment in Alzheimer's research, which could lead to new therapies and improved care.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_4202
Sponsor: Sen. Collins, Susan M. [R-ME]
Process start date: 2022-05-12
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Alzheimer’s Accountability and Investment Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_4202.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2022-05-12.

What are the main provisions?

Key points include:

  • Annual Budget Plans: The National Institutes of Health must submit a detailed annual budget for Alzheimer's research to the President and Congress.
  • Increased Funding Transparency: Citizens can expect greater transparency in how funds for Alzheimer's are spent, potentially leading to more efficient use of taxpayer money.
  • Potential for Increased Investment: The act aims to boost investment in Alzheimer's research, which could lead to new therapies and improved care.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Collins, Susan M. [R-ME].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health Public Investments